DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
当前地点:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators

DIGISONICS receives ASE certification for the ImageGuideEcho Registry

RAPID by iSchemaView now available for use in Mexico

Guerbet announces group purchasing agreement with Premier to distribute novel microcatheters

Merit Medical acquires Brightwater Medical

Keynote speakers for the opening day of its annual scientific session this September in Chicago

Cardinal Analytx and Optima Health enter into multiyear strategic alliance to improve care and reduce costs

MR plays a role in diagnosis of cocaine-related damage to the heart

Higher coronary artery calcium levels in middle-age may indicate higher risk for future heart problems

Materialise receives FDA clearance for cardiovascular planning software suite

First prospective registry confirms FFR impact treatment plans for patients with CAD

Press releases may be edited for formatting or style
LAS VEGAS (MAY 21, 2019) - A prospective, multicenter, multinational study examines how fractional flow reserve (FFR) can impact treatment plans and outcomes in patients with stable coronary artery disease (CAD) or acute coronary syndrome (ACS). Results showed more than one-third of the patients' initial treatment plans changed after FFR. The findings from the global registry are scheduled to be presented on Wednesday, May 22 as late-breaking clinical research at the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions.

According to the Centers for Disease Control (CDC), CAD is the most common type of heart disease killing more than 370,000 people a year in the United States. FFR is known to be an extremely accurate diagnostic tool for CAD and ACS patients. It offers a precise physiology technique to measure blood pressure and flow in a coronary artery, and has recently become a routine practice to help guide revascularization decisions for clinicians compared to angiography alone.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



In this registry, for the first time, treatment plans for patients were recorded prospectively rather than retrospectively following angiography, prior to performing FFR. Treatment options included medical therapy, percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Standard pre-defined clinical outcomes were also identified and recorded.

The PRESSUREwire "Practical Evaluation of Fractional Flow ReservE (FFR) and its ASsociated Alternate IndiceS DUring Routine Clinical ProcEdures" study enrolled more than 2,200 subjects across 70 hospitals in 15 countries between October 2016 - February 2018. Treatment plans based on angiography alone changed in 34 percent of patients post-FFR. Results showed approximately five percent more patients were planned for medical management post-FFR than post-angiography, fewer patients were assigned to PCI treatment post-FFR and more patients were assigned to CABG. There were no serious adverse events related to FFR measurement.

"Our registry data further validates numerous previous studies and reinforces the importance of using coronary physiology guidance in conjunction with angiography to guide the patient treatment plan," said lead author Erick Schampaert, MD, Hospital Sacre-Coeur De Montreal in Montreal, Canada. "Having accurate measurements can make a difference between a patient having an unnecessary invasive procedure or not intervening quickly enough when a patient does need further attention. Equipping physicians for better patient management has the potential to positively impact patient outcomes."

The authors of the study note the importance of incorporating FFR in daily clinical practice and recommend interventionalists to rely less on angiography alone, when non-invasive documentation of ischemia is not available.


About SCAI:
The Society for Cardiovascular Angiography and Interventions is a 5,000-member professional organization representing invasive and interventional cardiologists in approximately 75 nations. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
Jobs/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
Recently Certified
查看最近通过认证的用户
Recently Rated
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
Service Technicians Forum
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2019 DOTmed.com, Inc.
版权所有